Published in JAMA · View the paper (DOI)
An observational study of nearly 16,000 older adults with chronic kidney disease (CKD) found that higher doses of the muscle relaxant baclofen were associated with a greater risk of hospitalization due to encephalopathy. The study suggests that patients with CKD may need closer monitoring when prescribed baclofen.
Coverage from 2 institutions